mosunetuzumab-axgb

mosunetuzumab-axgb (LUNSUMIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

LUNSUMIO is a marketed brand name for mosunetuzumab-axgb. Check FDA Drugs@FDA for the current US label holder and prescribing information.

mosunetuzumab-axgb has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.